{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T17:11:59Z","timestamp":1778519519359,"version":"3.51.4"},"reference-count":65,"publisher":"Elsevier BV","issue":"16","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002923","name":"Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas","doi-asserted-by":"publisher","award":["PIP 112-201501-00631"],"award-info":[{"award-number":["PIP 112-201501-00631"]}],"id":[{"id":"10.13039\/501100002923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007351","name":"Secretaria de Ciencia y Tecnica, Universidad de Buenos Aires","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007351","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI-102254"],"award-info":[{"award-number":["AI-102254"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI-107663"],"award-info":[{"award-number":["AI-107663"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003074","name":"Agencia Nacional de Promoci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","award":["PICT 2015 1349"],"award-info":[{"award-number":["PICT 2015 1349"]}],"id":[{"id":"10.13039\/501100003074","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005363","name":"Universidad de Buenos Aires","doi-asserted-by":"publisher","award":["20020170100067BA"],"award-info":[{"award-number":["20020170100067BA"]}],"id":[{"id":"10.13039\/501100005363","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.bmc.2019.07.004","type":"journal-article","created":{"date-parts":[[2019,7,4]],"date-time":"2019-07-04T11:28:31Z","timestamp":1562239711000},"page":"3663-3673","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Synthesis and biological evaluation of 1-alkylaminomethyl-1,1-bisphosphonic acids against Trypanosoma cruzi and Toxoplasma gondii"],"prefix":"10.1016","volume":"27","author":[{"given":"Tamila","family":"Galaka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno N.","family":"Falcone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio H.","family":"Szajnman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia N.J.","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Docampo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan B.","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2019.07.004_b0005","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2174\/092986706775476043","article-title":"Progresses in the field of drug design to combat tropical protozoan parasitic diseases","volume":"13","author":"Li\u00f1ares","year":"2006","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.bmc.2019.07.004_b0010","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.2174\/1568026616666161025161858","article-title":"Clear shot at primary aim: susceptibility of Trypanosoma cruzi Organelles, structures and molecular targets to drug treatment","volume":"17","author":"Menna-Barreto","year":"2017","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.bmc.2019.07.004_b0015","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/jeu.12184","article-title":"Recent clinical trials for the etiological treatment of chronic chagas disease: advances challenges and perspectives","volume":"62","author":"Urbina","year":"2015","journal-title":"J Eukaryot Microbiol"},{"key":"10.1016\/j.bmc.2019.07.004_b0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003230","article-title":"Polyphosphate and its diverse functions in host cells and pathogens","volume":"9","author":"Moreno","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.bmc.2019.07.004_b0025","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1080\/13543776.2016.1209487","article-title":"Detection and treatment of Trypanosoma cruzi: a patent review (2011\u20132015)","volume":"26","author":"Rodriguez","year":"2016","journal-title":"Expert Opin Ther Pat"},{"key":"10.1016\/j.bmc.2019.07.004_b0030","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1056\/NEJMoa1313122","article-title":"Randomized trial of posaconazole and benznidazole for chronic Chagas\u2019 disease","volume":"370","author":"Molina","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bmc.2019.07.004_b0035","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S1471-4922(01)02093-1","article-title":"Toxoplasmosis: a persisting challenge","volume":"17","author":"L\u00fcder","year":"2001","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.bmc.2019.07.004_b0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1863-2378.2009.01276.x","article-title":"A Brief History and Overview of Toxoplasma gondii","volume":"57","author":"Innes","year":"2010","journal-title":"Zoonoses Public Health"},{"key":"10.1016\/j.bmc.2019.07.004_b0045","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1517\/13543776.2012.668886","article-title":"New antibacterials for the treatment of toxoplasmosis; a patent review","volume":"22","author":"Rodriguez","year":"2012","journal-title":"Expert Opin Ther Pat"},{"key":"10.1016\/j.bmc.2019.07.004_b0050","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/j.bmcl.2017.01.046","article-title":"Recent developments in drug discovery against the protozoal parasites crystosporidium and toxoplasma","volume":"27","author":"Chellan","year":"2017","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2019.07.004_b0055","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.ijpddr.2011.12.002","article-title":"Recent developments in sterol 14-demethylase inhibitors for chagas disease","volume":"2","author":"Buckner","year":"2012","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"10.1016\/j.bmc.2019.07.004_b0060","first-page":"66","article-title":"Targeting Trypanosoma cruzi sterol 14\u03b1-demethylase (CYP51)","volume":"75","author":"Lepesheva","year":"2011","journal-title":"Adv Parasitol"},{"key":"10.1016\/j.bmc.2019.07.004_b0065","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1084\/jem.20110039","article-title":"Apicoplast isoprenoid precursor synthesis and the molecular basis of fosmidomycin resistance in Toxoplasma gondii","volume":"208","author":"Nair","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.bmc.2019.07.004_b0070","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1517\/14728222.12.3.253","article-title":"Targeting the isoprenoid pathway of Toxoplasma gondii","volume":"12","author":"Moreno","year":"2008","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.bmc.2019.07.004_b0075","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1083\/jcb.149.1.167","article-title":"Toxoplasma gondii exploits host low-density lipoprotein receptor- mediated endocytosis for cholesterol acquisition","volume":"149","author":"Coppens","year":"2000","journal-title":"J Cell Biol"},{"key":"10.1016\/j.bmc.2019.07.004_b0080","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1128\/AAC.38.5.1144","article-title":"3-Hydroxy-3-methylglutaryl coenzyme a reductase inhibitors lovastatin and simvastatin inhibit in vitro development of Plasmodium falciparum and Babesia divergens in human erythrocytes","volume":"38","author":"Grellier","year":"1994","journal-title":"Antimicrob. Agents Chemother"},{"key":"10.1016\/j.bmc.2019.07.004_b0085","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1128\/AAC.01330-06","article-title":"Atorvastatin is 10-fold more active in vitro than Other Statins against Plasmodium falciparum","volume":"51","author":"Pradines","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmc.2019.07.004_b0090","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1128\/AAC.02460-12","article-title":"Drug repurposing screen reveals FDA-approved inhibitors of human HMG-CoA reductase and isoprenoid synthesis that block Cryptosporidium parvum Growth","volume":"57","author":"Bessoff","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmc.2019.07.004_b0095","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ijantimicag.2008.07.026","article-title":"Statins inhibit Toxoplasma gondii multiplication in macrophages in vitro","volume":"33","author":"Cortez","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.bmc.2019.07.004_b0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003665","article-title":"Toxoplasma gondii relies on both host and parasite Isoprenoids and can be rendered sensitive to atorvastatin","volume":"9","author":"Li","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.bmc.2019.07.004_b0105","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1517\/17460441.2016.1143814","article-title":"Approaches for designing new potent inhibitors of farnesyl pyrophosphate synthase","volume":"11","author":"Rodriguez","year":"2016","journal-title":"Expert Opin Drug Discov"},{"key":"10.1016\/j.bmc.2019.07.004_b0110","doi-asserted-by":"crossref","first-page":"17075","DOI":"10.1074\/jbc.M210467200","article-title":"Farnesyl pyrophosphate synthase is an essential enzyme in Trypanosoma brucei: in vitro RNA interference and in vivo inhibition studies","volume":"278","author":"Montalvetti","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2019.07.004_b0115","doi-asserted-by":"crossref","first-page":"6445","DOI":"10.1021\/jm300425y","article-title":"Design, synthesis, calorimetry, and crystallographic analysis of 2-alkylaminoethyl-1,1-bisphosphonates as inhibitors of Trypanosoma cruzi farnesyl diphosphate synthase","volume":"55","author":"Aripirala","year":"2012","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2019.07.004_b0120","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/prot.20754","article-title":"Structure and mechanism of the farnesyl diphosphate synthase from Trypanosoma cruzi: implications for drug design","volume":"62","author":"Gabelli","year":"2006","journal-title":"Proteins"},{"key":"10.1016\/j.bmc.2019.07.004_b0125","doi-asserted-by":"crossref","first-page":"8834","DOI":"10.1021\/ja020410i","article-title":"Recombinant squalene synthase. synthesis of non-head-to-tail isoprenoids in the absence of NADPH","volume":"124","author":"Jarstfer","year":"2002","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmc.2019.07.004_b0130","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/cmdc.201800693","article-title":"The role of the phosphorus atom in drug design","volume":"14","author":"Rodriguez","year":"2019","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bmc.2019.07.004_b0135","doi-asserted-by":"crossref","first-page":"30804","DOI":"10.1074\/jbc.M703178200","article-title":"The farnesyl-diphosphate\/geranylgeranyl-diphosphate synthase of Toxoplasma gondii is a bifunctional enzyme and a molecular target of bisphosphonates","volume":"282","author":"Ling","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2019.07.004_b0140","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1021\/cr9600464","article-title":"Enzymatic aspects of isoprenoid chain elongation","volume":"98","author":"Ogura","year":"1998","journal-title":"Chem Rev"},{"key":"10.1016\/j.bmc.2019.07.004_b0145","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.exppara.2008.02.013","article-title":"Farnesyl diphosphate synthase localizes to the cytoplasm of Trypanosoma cruzi and T. brucei","volume":"119","author":"Ferella","year":"2008","journal-title":"Exp Parasitol"},{"key":"10.1016\/j.bmc.2019.07.004_b0150","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1146\/annurev.pharmtox.38.1.375","article-title":"Mechanisms of action of bisphosphonates","volume":"38","author":"Rodan","year":"1998","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.bmc.2019.07.004_b0155","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.bone.2011.04.022","article-title":"Bisphosphonates: the first 40 years","volume":"49","author":"Russell","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.bmc.2019.07.004_b0160","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S8756-3282(99)00116-7","article-title":"Bisphosphonates: from the laboratory to the clinic and back again","volume":"25","author":"Russell","year":"1999","journal-title":"Bone"},{"key":"10.1016\/j.bmc.2019.07.004_b0165","doi-asserted-by":"crossref","first-page":"33609","DOI":"10.1074\/jbc.274.47.33609","article-title":"Trypanosoma cruzi contains major pyrophosphate stores, and its growth in vitro and in vivo is blocked by pyrophosphate analogs","volume":"274","author":"Urbina","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2019.07.004_b0170","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.ijantimicag.2003.07.019","article-title":"Antiparasitic activity of risedronate in a murine model of acute Chagas\u2019 disease","volume":"23","author":"Garzoni","year":"2004","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.bmc.2019.07.004_b0175","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s00436-005-1331-9","article-title":"Risedronate in the treatment of murine Chagas\u2019 disease","volume":"96","author":"Bouzahzah","year":"2005","journal-title":"Parasitol Res"},{"key":"10.1016\/j.bmc.2019.07.004_b0180","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.1021\/jm0102809","article-title":"Activity of bisphosphonates against Trypanosoma brucei rhodesiense","volume":"45","author":"Martin","year":"2002","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2019.07.004_b0185","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1021\/jm0002578","article-title":"Bisphosphonates inhibit the growth of Trypanosoma brucei, Trypanosoma cruzi, Leishmania donovani, Toxoplasma gondii, and Plasmodium falciparum: a potential route to chemotherapy","volume":"44","author":"Martin","year":"2001","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2019.07.004_b0190","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2174\/1568005013343191","article-title":"Bisphosphonates as chemotherapeutic agents against trypanosomatid and apicomplexan parasites","volume":"1","author":"Docampo","year":"2001","journal-title":"Curr Drug Target -Infectious Disord"},{"key":"10.1016\/j.bmc.2019.07.004_b0195","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ceca.2011.05.012","article-title":"Acidocalcisomes","volume":"50","author":"Docampo","year":"2011","journal-title":"Cell Calcium"},{"key":"10.1016\/j.bmc.2019.07.004_b0200","doi-asserted-by":"crossref","first-page":"882","DOI":"10.2174\/138161208784041079","article-title":"The acidocalcisome as a target for chemotherapeutic agents in protozoan parasites","volume":"14","author":"Docampo","year":"2008","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.bmc.2019.07.004_b0205","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nrmicro1097","article-title":"Acidocalcisomes - conserved from bacteria to man","volume":"3","author":"Docampo","year":"2005","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.bmc.2019.07.004_b0210","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1517\/13543776.2011.593511","article-title":"Farnesyl pyrophosphate synthase modulators: a patent review (2006\u20132010)","volume":"21","author":"Sun","year":"2011","journal-title":"Expert Opin Ther Pat"},{"key":"10.1016\/j.bmc.2019.07.004_b0215","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S0960-894X(01)00057-9","article-title":"Bisphosphonates derived from fatty acids are potent growth inhibitors of Trypanosoma cruzi","volume":"11","author":"Szajnman","year":"2001","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2019.07.004_b0220","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1016\/S0960-894X(03)00663-2","article-title":"Bisphosphonates derived from fatty acids are potent inhibitors of Trypanosoma cruzi farnesyl pyrophosphate synthase","volume":"13","author":"Szajnman","year":"2003","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2019.07.004_b0225","doi-asserted-by":"crossref","first-page":"4685","DOI":"10.1016\/j.bmcl.2005.07.060","article-title":"Synthesis and biological evaluation of 1-amino-1,1-bisphosphonates derived from fatty acids against Trypanosoma cruzi targeting farnesyl pyrophosphate synthase","volume":"15","author":"Szajnman","year":"2005","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2019.07.004_b0230","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1021\/jm040132t","article-title":"Bisphosphonate inhibitors of Toxoplasma gondii Growth: in vitro, QSAR, and in vivo investigations","volume":"48","author":"Ling","year":"2005","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2019.07.004_b0235","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1039\/c1ob06602a","article-title":"1-(Fluoroalkylidene)-1,1-bisphosphonic acids are potent and selective inhibitors of the enzymatic activity of Toxoplasma gondii farnesyl pyrophosphate synthase","volume":"10","author":"Szajnman","year":"2012","journal-title":"Org Biomol Chem"},{"key":"10.1016\/j.bmc.2019.07.004_b0240","doi-asserted-by":"crossref","first-page":"3283","DOI":"10.1016\/j.bmc.2007.12.010","article-title":"Synthesis and biological evaluation of 2-alkylaminoethyl-1,1-bisphosphonic acids against Trypanosoma cruzi and Toxoplasma gondii targeting farnesyl diphosphate synthase","volume":"16","author":"Szajnman","year":"2008","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2019.07.004_b0245","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1016\/j.bmc.2011.02.037","article-title":"Synthesis and biological evaluation of new 2-alkylaminoethyl-1,1-bisphosphonic acids against Trypanosoma cruzi and Toxoplasma gondii targeting farnesyl diphosphate synthase","volume":"19","author":"Rosso","year":"2011","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2019.07.004_b0250","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1021\/jm970860z","article-title":"Structure-activity relationship of new growth inhibitors of Trypanosoma cruzi","volume":"41","author":"Cinque","year":"1998","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2019.07.004_b0255","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.bmc.2013.11.010","article-title":"New insights into molecular recognition of 1,1-bisphosphonic acids by farnesyl diphosphate synthase","volume":"22","author":"Ferrer-Casal","year":"2014","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2019.07.004_b0260","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.ejmech.2012.12.015","article-title":"Design, synthesis and biological evaluation of sulfur-containing 1,1-bisphosphonic acids as antiparasitic agents","volume":"60","author":"Recher","year":"2013","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2019.07.004_b0265","doi-asserted-by":"crossref","first-page":"e02628","DOI":"10.1128\/AAC.02628-16","article-title":"Synergistic activity between statins and bisphosphonates against acute experimental toxoplasmosis","volume":"61","author":"Li","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmc.2019.07.004_b0270","doi-asserted-by":"crossref","first-page":"e01590","DOI":"10.1128\/AAC.01590-16","article-title":"In vitro and in vivo activities of sulfur-containing linear bisphosphonates against apicomplexan parasites","volume":"61","author":"Szajnman","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmc.2019.07.004_b0275","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3390\/molecules22010082","article-title":"Antiparasitic activity of sulfur- and fluorine-containing bisphosphonates against trypanosomatids and apicomplexan parasites","volume":"22","author":"Galaka","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.bmc.2019.07.004_b0280","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1021\/jm030084x","article-title":"Effects of Bisphosphonates on the growth of Entamoeba histolytica and Plasmodium Species in vitro and in vivo","volume":"47","author":"Ghosh","year":"2004","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2019.07.004_b0285","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.3762\/bjoc.12.146","article-title":"Microwave-assisted synthesis of (aminomethylene)bisphosphine oxides and (aminomethylene)bisphosphonates by a three-component condensation","volume":"12","author":"B\u00e1lint","year":"2016","journal-title":"Beisltein J Org Chem"},{"key":"10.1016\/j.bmc.2019.07.004_b0290","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1248\/cpb.41.688","article-title":"Studies on novel bone resorption inhibitors. I. Synthesis and pharmacological activities of aminomethylenebisphosphonate derivatives","volume":"41","author":"Takeuchi","year":"1993","journal-title":"Chem Pharm Bull"},{"key":"10.1016\/j.bmc.2019.07.004_b0295","doi-asserted-by":"crossref","first-page":"3806","DOI":"10.1016\/j.jorganchem.2009.07.025","article-title":"Insight into the mechanism of three component condensation leading to aminomethylenebisphosphonates","volume":"694","author":"D\u0105browska","year":"2009","journal-title":"J Organomet Chem"},{"key":"10.1016\/j.bmc.2019.07.004_b0300","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0022-328X(02)01179-8","article-title":"Michael addition of grignard reagents to tetraethyl ethenylidenebisphosphonate","volume":"650","author":"Lolli","year":"2002","journal-title":"J Organomet Chem"},{"key":"10.1016\/j.bmc.2019.07.004_b0305","doi-asserted-by":"crossref","first-page":"3687","DOI":"10.1002\/ejoc.200500097","article-title":"New insights into the chemistry of gem-bis(phosphonates): unexpected rearrangement of michael-type acceptors","author":"Szajnman","year":"2005","journal-title":"Euro J Org Chem"},{"key":"10.1016\/j.bmc.2019.07.004_b0310","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1055\/s-0033-1340952","article-title":"Tetraethyl vinylidenebisphosphonate: a versatile synthon for the preparation of bisphosphonates","volume":"46","author":"Rodriguez","year":"2014","journal-title":"Synthesis"},{"key":"10.1016\/j.bmc.2019.07.004_b0315","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1039\/c39790000739","article-title":"Functional selectivity in phosphonate ester dealkylation with bromotrimethylsilane","volume":"17","author":"McKenna","year":"1979","journal-title":"J Chem Soc, Chem Commun"},{"key":"10.1016\/j.bmc.2019.07.004_b0320","doi-asserted-by":"crossref","first-page":"4573","DOI":"10.1021\/jo00335a053","article-title":"Fluorination of methanediphosphanate esters by perchloryl fluoride. synthesis of fluoromethanediphosphonic acids and difluoromethanediphosphonic acid","volume":"46","author":"McKenna","year":"1981","journal-title":"J Org Chem"},{"key":"10.1016\/j.bmc.2019.07.004_b0325","doi-asserted-by":"crossref","first-page":"5967","DOI":"10.1021\/jm0702884","article-title":"Synthesis and biological evaluation of alpha-halogenated bisphosphonate and phosphonocarboxylate analogues of risedronate","volume":"50","author":"Marma","year":"2007","journal-title":"J Med Chem"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089619307400?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089619307400?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T16:47:01Z","timestamp":1778518021000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089619307400"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":65,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S0968089619307400"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2019.07.004","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and biological evaluation of 1-alkylaminomethyl-1,1-bisphosphonic acids against Trypanosoma cruzi and Toxoplasma gondii","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2019.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}